Skip to main content

Advertisement

Log in

Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

We conducted an individual participant data (IPD) pooled analysis on diagnostic accuracy of MRE to detect fibrosis stage in patients with non-alcoholic fatty liver disease (NAFLD).

Methods

Through a systematic literature search, we identified studies of MRE (at 60–62.5 Hz) for staging fibrosis in patients with NAFLD, using liver biopsy as gold standard, and contacted study authors for IPD. Through pooled analysis, we calculated the cluster-adjusted AUROC, sensitivity and specificity of MRE for any (≥stage 1), significant (≥stage 2) and advanced (≥stage 3) fibrosis and cirrhosis (stage 4).

Results

We included nine studies with 232 patients with NAFLD (mean age, 51 ± 13 years; 37.5 % males; mean BMI, 33.5 ± 6.7 kg/m2; interval between MRE and biopsy <1 year, 98.3 %). Fibrosis stage distribution (stage 0/1/2/3/4) was 33.6, 32.3, 10.8, 12.9 and 10.4 %, respectively. Mean AUROC (and 95 % CIs) for diagnosis of any, significant or advanced fibrosis and cirrhosis was 0.86 (0.82–0.90), 0.87 (0.82–0.93), 0.90 (0.84–0.94) and 0.91 (0.76–0.95), respectively. Similar diagnostic performance was observed in stratified analysis based on sex, obesity and degree of inflammation.

Conclusions

MRE has high diagnostic accuracy for detection of fibrosis in NAFLD, independent of BMI and degree of inflammation.

Key points

MRE has high diagnostic accuracy for detection of fibrosis in NAFLD.

BMI does not significantly affect accuracy of MRE in NAFLD.

Inflammation had no significant influence on MRE performance in NAFLD for fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lazo M, Hernaez R, Eberhardt MS et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 178:38–45

    Article  PubMed  PubMed Central  Google Scholar 

  2. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285

    Article  CAS  PubMed  Google Scholar 

  3. Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609

    Article  PubMed  Google Scholar 

  4. Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690

    Article  CAS  PubMed  Google Scholar 

  5. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500

    Article  CAS  PubMed  Google Scholar 

  6. Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618

    Article  PubMed  Google Scholar 

  7. Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142:1293–1302 e1294

    Article  PubMed  Google Scholar 

  8. Castera L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835

    PubMed  Google Scholar 

  9. Bota S, Sporea I, Sirli R et al (2014) Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography: analysis of a cohort of 1,031 subjects. Eur J Radiol 83:268–272

    Article  PubMed  Google Scholar 

  10. Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37:544–555

    Article  PubMed  PubMed Central  Google Scholar 

  11. Singh S, Venkatesh SK, Wang Z et al (2014) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: A systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2014.09.046

    Google Scholar 

  12. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL (2013) Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 268:411–419

    Article  PubMed  PubMed Central  Google Scholar 

  13. Loomba R, Wolfson T, Ang B et al (2014) Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. doi:10.1002/hep.27362

    Google Scholar 

  14. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269, W264

    Article  PubMed  Google Scholar 

  15. Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340:c221

    Article  PubMed  Google Scholar 

  16. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293

    Article  CAS  PubMed  Google Scholar 

  17. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pepe MS (2000) Receiver operating characteristic methodology. J Am Stat Assoc 95:308–311

    Article  Google Scholar 

  19. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    Article  CAS  PubMed  Google Scholar 

  20. Jaeschke R, Guyatt GH, Sackett DL (1994) Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703–707

    Article  CAS  PubMed  Google Scholar 

  21. Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219

    Article  PubMed  PubMed Central  Google Scholar 

  22. Asbach P, Klatt D, Hamhaber U et al (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373–379

    Article  PubMed  Google Scholar 

  23. Asbach P, Klatt D, Schlosser B et al (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257:80–86

    Article  PubMed  Google Scholar 

  24. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756

    Article  PubMed  PubMed Central  Google Scholar 

  25. Godfrey EM, Patterson AJ, Priest AN et al (2012) A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22:2790–2797

    Article  PubMed  Google Scholar 

  26. Low RN, Hassanein T (2012) MR elastography: validation and reproducibility of measurements of mean liver stiffness and fibrosis. J Hepatol 56:S415

    Article  Google Scholar 

  27. Rustogi R, Horowitz J, Harmath C et al (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356–1364

    Article  PubMed  PubMed Central  Google Scholar 

  28. Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553–561

    Article  PubMed  PubMed Central  Google Scholar 

  29. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213.e1202

    Article  PubMed  PubMed Central  Google Scholar 

  30. Batheja MJ, Silva AC, De Petris G, Vargas H (2011) Role of magnetic resonance elastography in assessing hepatic fibrosis. Gastroenterology (1):S927

  31. Bohte AE, de Niet A, Jansen L et al (2014) Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 24:638–648

    Article  PubMed  Google Scholar 

  32. Choi YR, Lee JM, Yoon JH, Han JK, Choi BI (2013) Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Investig Radiol 48:607–613

    Article  CAS  Google Scholar 

  33. Crespo S, Bridges MD, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP (2010) Magnetic resonance elastography compared with liver biopsy in evaluating fibrosis due to recurrent HCV after liver transplantation. Am J Transplant 10:157

    Article  Google Scholar 

  34. Huwart L, Peeters F, Sinkus R et al (2006) Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 19:173–179

    Article  PubMed  Google Scholar 

  35. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466

    Article  PubMed  Google Scholar 

  36. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32–40

    Article  PubMed  Google Scholar 

  37. Ichikawa S, Motosugi U, Ichikawa T et al (2012) Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 11:291–297

    Article  PubMed  Google Scholar 

  38. Kim BH, Lee JM, Lee YJ et al (2011) MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging 34:1110–1116

    Article  PubMed  Google Scholar 

  39. Klatt DAP, Kamphues C, Hirsch S, Papazoglou S, Braun J, Sack I (2011) MR elastography of liver transplant patients using parallel imaging techniques. Proc Int Soc Magn Reson Med 19:1485

    Google Scholar 

  40. Lee VS, Miller FH, Omary RA et al (2011) Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation 92:581–586

    Article  PubMed  Google Scholar 

  41. Nguyen D, Talwalkar JA, Yin M, Lindor KD, Ehman RL (2011) Assessment of hepatic fibrosis by magnetic resonance elastography in patients with sclerosing cholangitis. Gastroenterology (1):S919

  42. Venkatesh SK, Wang G, Lim SG, Wee A (2013) Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. doi:10.1007/s00330-013-2978-8:1-9

    PubMed  Google Scholar 

  43. Yoon JH, Lee JM, Woo HS et al (2013) Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol 14:202–212

    Article  PubMed  PubMed Central  Google Scholar 

  44. Rouviere O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240:440–448

    Article  PubMed  Google Scholar 

  45. Xanthakos SA, Podberesky DJ, Serai SD et al (2014) Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. J Pediatr 164:186–188

    Article  PubMed  Google Scholar 

  46. Wong VW, Vergniol J, Wong GL et al (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462

    Article  CAS  PubMed  Google Scholar 

  47. Naveau S, Lamouri K, Pourcher G et al (2014) The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg 24:1693–1701

    Article  PubMed  Google Scholar 

  48. Kwok R, Tse YK, Wong GL et al (2014) Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease: the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 39:254–269

    Article  CAS  PubMed  Google Scholar 

  49. Myers RP, Pomier-Layrargues G, Kirsch R et al (2012) Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 56:564–570

    Article  PubMed  Google Scholar 

  50. Petta S, Di Marco V, Camma C, Butera G, Cabibi D, Craxi A (2011) Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 33:1350–1360

    Article  CAS  PubMed  Google Scholar 

  51. Myers RP, Pomier-Layrargues G, Kirsch R et al (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55:199–208

    Article  PubMed  Google Scholar 

  52. Kim SU, Kim JK, Park YN, Han KH (2012) Discordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS One 7, e32233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Tapper EB, Cohen EB, Patel K et al (2012) Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 10:932–937 e931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Ichikawa S, Motosugi U, Nakazawa T et al (2014) Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging. doi:10.1002/jmri.24666

    Google Scholar 

  55. Singh S, Fujii LL, Murad MH et al (2013) Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:1573–1584 e1-2, quiz e1588–1579

    Article  PubMed  PubMed Central  Google Scholar 

  56. Loomba R, Sirlin CB, Ang B et al (2014) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel MRI and MRE in a randomized trial (MOZART Trial). Hepatology. doi:10.1002/hep.27647

    Google Scholar 

Download references

Acknowledgments

We wish to thank Ms. Patricia Erwin, M.L.S., Senior Medical Librarian at the Mayo Clinic Library for helping in the literature search for this systematic review and meta-analysis.

The scientific guarantor of this publication is Sudhakar K. Venkatesh.

The authors of this manuscript declare relationships with the following companies: This work is supported in part by National Institute of Health (NIH) grant EB001981 to MY, JC and RLE and American Gastroenterological Association (AGA) Foundation – Sucampo – ASP Designated Research Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award and grant K23-DK090303-04 to RL. MY, JC, RLE and the Mayo Clinic have intellectual property relating to the subject and may be eligible for royalties from licensing. RLE is CEO of Resoundant, Inc. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies. None of the other authors have any disclosures. This study received funding from the NIH to RL, MY and JC. Two of the authors have significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board.

Some study subjects or cohorts have been previously reported in Singh S. et al. (2014) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: A systematic review and meta-analysis of individual participant data. Clinical Gastroenterology and Hepatology 2015;13:440–451. Methodology: retrospective, observational, multicentre study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudhakar K. Venkatesh.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 138 kb)

ESM 2

(DOCX 35 kb)

Supplementary Fig. 1

Cluster-adjusted pooled area under receiver operator curve (AUROC) of MRE for diagnosis of any (≥stage 1), significant (≥stage 2) or advanced (≥stage 3) fibrosis and cirrhosis (GIF 95 kb)

High resolution image (TIFF 154 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Venkatesh, S.K., Loomba, R. et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26, 1431–1440 (2016). https://doi.org/10.1007/s00330-015-3949-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3949-z

Keywords

Navigation